From: Walsh, Maria R
Sent: Wednesday, October 27, 2004 8:32 AM
To: Butler, Jennie C
Cc: Kang, Kyong A
Subject: FW: Public Meeting Nov 16th

Jennie,

I received a presentation in Power Point for Docket 2004N-0432.

Maria

-----Original Message-----
From: Eric J. Hall [mailto:ejh1@columbia.edu] 
Sent: Tuesday, October 26, 2004 4:04 PM
To: Walsh, Maria R
Subject: Re: Public Meeting Nov 16th


Dear Ms. Walsh,

Thank you for notifying me that I am scheduled to present at the November 16th RDRC public meeting during the 10:00-11:00 am public presentation period.

Please find attached my presentation in PowerPoint. It consists of ten slides for which 10 minutes should be more than adequate.

Sincerely,

Eric Hall


----- Original Message ----- 
From: "Walsh, Maria R" <WALSH@cder.fda.gov>
To: "'Eric J. Hall'" <ejh1@columbia.edu>
Sent: Tuesday, October 26, 2004 12:12 PM
Subject: RE: Public Meeting Nov 16th


> Dr. Hall,
>
> You are scheduled to present at the November 16th RDRC public meeting
during
> the 10:00-11:00 am public presentation period. Your name will appear 
> on
the
> agenda as follows:
>
> Eric J. Hall, PhD, RDRC Chair, Professor of Radiation Biophysics, 
> Columbia University
>
> Please let me know if you have any edits by COB November 1, 2004.
>
> Thank you.
>
> Maria
>
> Maria R. Walsh, RN, MS
> Project Management Officer
>
> FDA/CDER/OND
> Office of Drug Evaluation III Immediate Office (HFD-103)
> 5600 Fishers Lane
> Rockville, Maryland 20857
> Phone: (301) 827-3139
> Fax: (301) 480-3761
> e-mail: walsh@cder.fda.gov
>
>
> -----Original Message-----
> From: Eric J. Hall [mailto:ejh1@columbia.edu]
> Sent: Friday, October 08, 2004 10:30 AM
> To: Walsh, Maria R
> Cc: Suleiman, Orhan
> Subject: Public Meeting Nov 16th
>
>
> Dear Ms. Walsh,
> I wish to present information at the public meeting on  "Radioactive 
> Drugs for Certain Research Uses" on Nov 16th. Name; Eric J. Hall 
> D.Phil D.Sc.
FACR
> FRCR Higgins Professor of Radiation Biophysics, Columbia University, 
> 630, West 168th St., New York. N.Y.10032 Tel. (212) 305 5660
> e-mail address   ejh1@columbia.edu
> Question;  Radiation Dose Limits.
> Time needed; 10minutes
> Abstract;
>
>     The present dose limits for research subjects date from the 
> 1970's. Since then the BEIR and UNSCEAR committees have revised their 
> cancer risk estimates and NCRP has reduced the maximum permissible 
> dose limits.
>
>     Dose limits for Research Subjects are linked to occupational 
> exposure limits and so it follows that they should now be reduced.  A 
> simplified system of dose limits for adults will be suggested.
>
>     As the Japanese A-bomb data has matured, it has become evident 
> that young children are much more sensitive to radiation induced 
> cancer than adults.  It may be justified to have 3, instead of 2, age 
> ranges namely
0-5
> yrs, 5 to 18 yrs and over 18 years, with dose reduction factors of 15 
> and
10
> respectively for the children that are under 18 yrs of age.
>
> NOTE:  I should disclose that I am a consultant to the FDA.  If this
request
> is granted, I will submit a microsoft powerpoint presentation by 
> November the 2nd.
>
> Sincerely,
> Eric J. Hall
>